title: Etanercept therapy in a hepatitis B virus (HBV)-positive psoriatic patient developing a monoclonal gammopathy of undetermined significance.
authors.affiliation: Department of Dermatology, Florence University, Italy. francesca.prignano@unifi.it
authors.forename: Francesca
authors.initials: F
authors.lastname: Prignano
authors.forename: Federica
authors.initials: F
authors.lastname: Ricceri
authors.forename: Leonardo
authors.initials: L
authors.lastname: Pescitelli
authors.forename: Diletta
authors.initials: D
authors.lastname: Bonciani
authors.forename: Torello
authors.initials: T
authors.lastname: Lotti
mesh_terms: D000068800:Etanercept; D019694:Hepatitis B, Chronic / Q000150:complications*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000150:complications*; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept